Research Pulse podcast Season 2 Episode 6
Ovarian cancer often remains undiagnosed until an advanced stage of disease, and may be resistant to available treatments.
Our guest is Dr Melissa Pitman, ovarian cancer researcher at the Centre for Cancer Biology.
We learn about:
- why ovarian cancer is known as the ‘silent killer’
- why chemotherapy resistance is a major problem when treating ovarian cancer
- how Dr Pitman is using lab models to understand why some cancers become resistant and how they can be re-sensitised to treatment.
About the research
Dr Melissa Pitman is the head the Ovarian Cancer and Drug Discovery Laboratory at the University of Adelaide. Dr Pitman works with the Molecular Therapeutics Laboratory at the Centre for Cancer Biology/SA Pathology and Reproductive Cancer Research Group at the University of Adelaide. Dr Pitman’s work is focussed on the identification and testing of novel therapeutic agents for the treatment of ovarian cancer, with a major focus on the development and use of preclinical models of this disease.
If you’re interested in discussing working with Dr Pitman, you can email her here.
Listen and subscribe
To listen to upcoming episodes, find us and subscribe wherever you get your podcasts.
Share on social
Enjoy listening to Research Pulse? Share with your colleagues, friends and family and let your network know about what you’re listening to.
Feedback
We would love to know what you think of the Research pulse podcast or if you have an idea about a topic for a future episode, we’d love to hear from you.
